Metsera

Metsera FCF Conversion

Delisted

The FCF Conversion Rate (FCF/EBITDA) of Metsera (MTSR) as of Nov 3, 2026 is 47.74 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 75.04 % — a change of -36.38% (lower).

FCF Conversion

47.74 %

YoY

-36.38%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Metsera is 2024 47.74 % . FCF Conversion Rate (FCF/EBITDA) of Metsera was 2023 75.04 % . It decreases by -36.38% lower compared to the previous year.

The Metsera FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2022
66.05 USD
Jan 1, 2023
75.04 USD
Jan 1, 2024
47.74 USD
The Metsera FCF Conversion history
YEARFCF ConversionYoY
47.74 %-36.38%
75.04 %+13.60%
66.05 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Metsera Stock analysis

What does Metsera do? Metsera Inc. is a clinical stage biopharmaceutical company based in New York City, operating in the Health Care sector with a focus on Biotechnology. The company develops next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides for treating obesity and related conditions. Utilizing its proprietary MINT peptide library, HALO half-life extension platform, and MOMENTUM oral delivery system, Metsera has a pipeline including MET-097i, MET-233i, and MET-224o, targeting various obesity treatments with differentiated approaches. Listed on 31 January 2025, the company employs 82 staff. Metsera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Metsera stock

FCF Conversion Rate (FCF/EBITDA) of Metsera is 47.74 % in 2024.

FCF Conversion Rate (FCF/EBITDA) of Metsera changed from 75.04 % to 47.74 %, representing a -36.38% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Metsera since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Metsera with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Metsera

All Key Metrics — Metsera